A detailed history of Avantax Planning Partners, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 50,000 shares of BLUE stock, worth $389,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$389,500
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.47 - $1.35 $23,500 - $67,500
50,000 New
50,000 $26,000
Q2 2018

Aug 13, 2018

SELL
$99.64 - $127.59 $2,590 - $3,317
-26 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$105.8 - $150.94 $2,750 - $3,924
26 New
26 $4,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $601M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.